|

[64Cu]FBP8 Clinical Trials

2 actively recruiting trials across 1 location

Also known as: 64Cu-FBP8, Positron Emission Tomography dye

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • Massachusetts General Hospital2

Indications

  • Alzheimer's Disease1
  • COVID-191
  • Heart Disease1
  • Dementia of Alzheimer Type1
  • Atrial Fibrillation1

Boston, Massachusetts2 trials

Assess Fibrin in Brains With AD/ADRD

Massachusetts General Hospital

Phase 1/2
Positron Emission Tomography (PET) Imaging of Thrombosis

Massachusetts General Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.